T2DM (Type 2 Diabetes Mellitus) Clinical Trials

88 clinical trials for T2DM (Type 2 Diabetes Mellitus) across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus — RECRUITING · PHASE2
• A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus — RECRUITING · PHASE2
• A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease. — RECRUITING · PHASE2
• Anti-inflammatory Dietary Intervention in Patients With Type 2 Diabetes: A Randomized Controlled Trial — RECRUITING · NA
• A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus — RECRUITING · PHASE2
• Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D — RECRUITING
• A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus — RECRUITING · PHASE1
• GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM — RECRUITING · PHASE4
• Effects of Calcium on Gut Functions and Blood Glucose in Humans With Type 2 Diabetes — RECRUITING · NA
• Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control — RECRUITING · PHASE4
• Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine — RECRUITING · NA
• Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin — RECRUITING · PHASE3
• Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes. — RECRUITING · PHASE4
• Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients — RECRUITING · NA
• The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy — RECRUITING
• Comprehensive Clinical Evaluation Study of GLP-1RA — RECRUITING
• To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM — RECRUITING · NA
• Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) — RECRUITING · PHASE2
• Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes — COMPLETED · PHASE3
• Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin — COMPLETED · PHASE3
• Virtual Diabetes Group Visits Across Health Systems — ACTIVE_NOT_RECRUITING · NA
• Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health — NOT_YET_RECRUITING
• Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease — NOT_YET_RECRUITING · NA
• To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus — NOT_YET_RECRUITING · PHASE3
• Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin — COMPLETED · PHASE3
• Chiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes — NOT_YET_RECRUITING
• A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus — ACTIVE_NOT_RECRUITING · PHASE2
• Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease — NOT_YET_RECRUITING · PHASE4
• Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets — NOT_YET_RECRUITING · NA
• Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets — NOT_YET_RECRUITING · PHASE1
• The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD — NOT_YET_RECRUITING · PHASE4
• Detecting Type 2 Diabetes From Voice — COMPLETED
• Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type 2 Diabetes Mellitus — NOT_YET_RECRUITING
• Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets — NOT_YET_RECRUITING · NA
• Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients — TERMINATED · NA
• Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease — NOT_YET_RECRUITING · PHASE4
• A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both — COMPLETED · PHASE3
• Glycemia and Antibiotic Efficacy in Diabetic Recurrent UTIs — COMPLETED · NA
• Metabolic Surgery for Metabolic Syndrome — COMPLETED
• The Effect of Semaglutide on Bone Health — NOT_YET_RECRUITING · PHASE4
• Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers — ACTIVE_NOT_RECRUITING
• A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients — COMPLETED · PHASE3
• A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone — NOT_YET_RECRUITING · PHASE3
• A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes — NOT_YET_RECRUITING · PHASE3
• A Study of RAY1225 in Participants With Type 2 Diabetes — ACTIVE_NOT_RECRUITING · PHASE2
• Utilization Study and Evaluation of Educational Intervention on HbA1c Testing — ACTIVE_NOT_RECRUITING · NA
• A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM — COMPLETED · PHASE3
• Group Emotion-Focused Behavioral Intervention for Diabetes Distress/A1c in T2D. — NOT_YET_RECRUITING · NA
• Hydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 Diabetes — COMPLETED
• Embecta AID System in Adults With Type 2 Diabetes — WITHDRAWN · NA

Refine this search